30 Dec 2018

BOSTON SCIENTIFIC ACQUIRING BTG

Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders of BTG’s

0
25 Dec 2018

WALL STREET JOURNAL: STRYKER MAKES OFFER TO TAKE OVER BOSTON SCIENTIFIC

Stryker has made a quiet offer to acquire its rival Boston Scientific, which would create a behemoth with $21.5 billion in annual sales through one of the largest medical device deals on record, according to a report from the Wall Street Journal. The combined company could tout up to 62,000 employees and

0
22 Dec 2018

ANGIODYNAMICS TO PRESENT AT JAN. 9 AT J.P. MORGAN HEALTHCARE CONFERENCE

AngioDynamics, Inc. , a provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, has announced that Jim Clemmer, president and CEO, and Michael C. Greiner, executive vice president and CFO, will present at the 37th Annual J.P. Morgan Healthcare Conference at 3 p.m. (PT) on

0
21 Dec 2018

FDA SEEKS COMMENTS ON UPDATE RADIATION CONTROL RULES BY FEB. 19

By AuntMinnie.com The U.S. Food and Drug Administration (FDA) has issued a draft guidance for an update to its radiation control regulations covering the manufacturing of diagnostic x-ray equipment. The guidance will supersede previous rules issued in 1989. Titled “Clarification of radiation control regulations for manufacturers of diagnostic x-ray equipment,”

0
fraud definition photo
21 Dec 2018

RANSOMWARE CYBER ATTACKS CONTINUE IN NORTH AMERICA

    More than one-in-four (27 percent) North America-based health IT employees admit that their employer has experienced a ransomware cybersecurity attack within the past year, according to cybersecurity company Kaspersky Lab’s latest report, “Cyber Pulse: The State of Cybersecurity in Healthcare.” Employees of healthcare organizations in the U.S. and Canada,

0
21 Dec 2018

CIGNA CLOSES $67 BILLION PURCHASE OF EXPRESS SCRIPTS DEC. 20

    Cigna officially absorbed one of the largest pharmacy benefit managers in the country on Dec. 20, closing its $67 billion purchase of Express Scripts.   The acquisition gives Cigna significant leverage in a market in which insurers are increasingly partnering, acquiring or being bought by PBMs. With Express

0
20 Dec 2018

MCAFEE: CRYPTOMINING AND IoT MALWARE BOTH ROSE OVER 70% IN Q3 2018

    By DeanTakahashi VentureBeat   Cybersecurity firm McAfee said that the cybercriminal underworld is generating 480 new threats per minute. That’s one of the details in the new McAfee Labs Threats Report: December 2018.   McAfee reported that internet of things malware was up 73 percent in the third quarter, while cryptocurrency

0
19 Dec 2018

MEDTRONIC COMPLETES ACQUISITION OF MAZOR ROBOTICS

Medtronic plc   completed the acquisition of Israel-based Mazor Robotics Dec. 19. Under the terms of the acquisition agreement, Mazor shareholders will receive $58.50 per ADS, or $29.25 per ordinary share, in cash. The total value of the transaction is reported at $1.7B, or $1.3B net of Medtronic’s existing stake in Mazor

0
18 Dec 2018

MERIT MEDICAL ACQUIRES ASSETS OF VASCULAR INSIGHTS DEC 17

  Merit Medical Systems Inc., a manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, announced Dec. 17 that it has acquired substantially all of the assets of Vascular Insights LLC, based in Quincy, Massachusetts. Vascular Insights’ primary assets are the ClariVein IC and ClariVein

0
14 Dec 2018

VOLUNTARY MACRA CODES MAY DETERMINE WHAT DOCTORS ARE PAID

New patient relationship categories and codes are one of the most important provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), according to a piece in the New England Journal of Medicine. In January 2018, the billing-code modifiers, which allow clinicians to report their relationship to a patient at a

0